Sign Up to like & get
recommendations!
1
Published in 2020 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2008190117
Abstract: Significance Virus-neutralizing monoclonal antibodies have been tested for the treatment or prevention of HIV-1 infection. Such an antibody can block virus infectivity and mediate killing of virus-infected cells by Fc-mediated effector functions. The relative contributions…
read more here.
Keywords:
effector functions;
antiviral activity;
hiv;
antibody ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2016.0299
Abstract: It has been known for more than 30 years that HIV-1 infection drives a very potent B cell response resulting in the production of anti-HIV-1 antibodies targeting several viral proteins, particularly its envelope glycoproteins (Env).…
read more here.
Keywords:
antibody;
effector function;
mediated effector;
neutralizing antibodies ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Experimental Botany"
DOI: 10.1093/jxb/erz571
Abstract: Inducible expression of AvrRps4 activates RRS1/RPS4-mediated effector-triggered immunity without the presence of pathogens, allowing us to characterize downstream immune responses triggered by TIR-NLRs without cell surface receptor-mediated immunity.
read more here.
Keywords:
effector triggered;
triggered immunity;
expression;
mediated effector ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Journal of Immunotherapy (Hagerstown, Md. : 1997)"
DOI: 10.1097/cji.0000000000000465
Abstract: Siglec-15, an inhibitory immune checkpoint, is an emerging target in cancer immunotherapy. Blocking the function of Siglec-15 is an excellent strategy for cancer treatment and antibody blockade has been used to target Siglec-15. However, whether…
read more here.
Keywords:
enhancing anti;
potency;
mediated effector;
effector functions ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cell reports"
DOI: 10.1101/2022.02.21.481308
Abstract: Non-neutralizing antibodies (nnAbs) can eliminate HIV-1-infected cells via antibody-dependent cellular cytotoxicity (ADCC) and were identified as a correlate of protection in the RV144 vaccine trial. Fc-mediated effector functions of nnAbs were recently shown to alter…
read more here.
Keywords:
hiv vpu;
vpu restricts;
mediated effector;
vpu ... See more keywords